Produktbild
Chandan Kumar

Studies with beta particle emitting radionuclide for cancer therapy

Buch

Use of radiation is well established primary modalities for the treatment of various cancers. Radionuclides therapy using radiopharmaceuticals are very effective in certain cancers, such as thyroid cancer and tumor micrometastasis. Radionuclides therapy is most often accomplished by using radioisotopes capable of emitting alpha and/or beta, as it is important to deliver the radiation dose to the target tissue, while sparing the neighboring healthy tissues. In this context,131I has been used for therapy since more than six decades to treat thyroid disorder and is still among the most promising therapeutic radionuclide. While thyroid cancer has… Mehr

CHF 68.00

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen

Produktdetails


  • ISBN: 978-3-330-04354-1
  • EAN: 9783330043541
  • Produktnummer: 37543937
  • Verlag: LAP Lambert Academic Publishing
  • Sprache: Englisch
  • Erscheinungsjahr: 2017
  • Seitenangabe: 120 S.
  • Masse: H22.0 cm x B15.0 cm x D0.7 cm 197 g
  • Abbildungen: Paperback
  • Gewicht: 197

Über den Autor


Author has been working in the field of nuclear medicine & radiation biology with major emphasis on imaging and therapy of cancer. The major focus of his work is to understand the basic mechanisms of cancer cell death under the influence of radionuclide therapy. He is also combining various therapeutic approaches to enhance efficacy of cell death.

28 weitere Werke von Chandan Kumar:


Bewertungen


0 von 0 Bewertungen

Geben Sie eine Bewertung ab!

Teilen Sie Ihre Erfahrungen mit dem Produkt mit anderen Kunden.